HIFEM Therapy for Health & Longevity - Quick Reference Sheet

HIFEM Therapy for Health & Longevity

Created on 07/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

HIFEM uses a strong magnetic field to force powerful muscle contractions, building muscle and lowering fat in the treated area. Its clearest effects are cosmetic; a seated version may ease urine leakage. Broader health and longevity benefits stay unproven, and the evidence is short-term and largely industry-funded. It does not replace exercise. (Full Review)

Protocol

Standard Course
4 sessions
Four 30-minute sessions over ~2 weeks (~2 per week)
Intensity
Maximum tolerable
Ramp to the highest comfortable output each session
Maintenance
Every 3–6 months
A single session to preserve results
Time to effect
Measurable Change
2–4 weeks
Muscle and fat changes appear after the course
Peak Effect
~3 months
Muscle and fat effects reach their maximum
Sensation
Immediate
Contractions are felt during the session

Benefits

Contraindications
  • Cardiac pacemakers or defibrillators
  • Implanted neurostimulators or drug pumps
  • Any electronic or metal implant in or near the field
  • Pregnancy
  • Abdominal or umbilical hernia in the field (relative)
  • Recent surgery at the site, within 3–6 months (relative)
  • Active malignancy in the treatment area (relative)
  • Uncontrolled epilepsy (relative)
  • Copper intrauterine device, pelvic application (relative)
  • Metal joint replacements near the field (relative)
Key Interactions
  • Anticoagulants or antiplatelet drugs (warfarin, apixaban, clopidogrel)
  • Seizure-threshold-lowering drugs (bupropion, tramadol)

Risk & Side Effects

  • High: Transient muscle soreness and fatigue
  • Medium: Local skin redness, warmth, and heat effects; muscle cramping or spasm during treatment
  • Low: Worsening of an abdominal hernia; interference with electronic or metallic implants
  • Speculative: Non-durable results and fat or muscle rebound; unknown long-term effects of repeated supramaximal contraction

Monitoring

Marker Target Why
Waist circumference Men <94 cm; women <80 cm Tracks abdominal fat and treatment response
Body fat percentage Men ~10–20%; women ~18–28% Distinguishes local contouring from whole-body change
Skeletal muscle index Men ≥7.0 kg/m²; women ≥5.5 kg/m² Establishes baseline muscle status; screens for sarcopenia
Handgrip strength Men ≥27 kg; women ≥16 kg A whole-body strength proxy tied to healthy aging
Treated-area muscle and fat thickness Individualized vs baseline The direct, objective measure of the local effect
Fasting glucose / HbA1c Glucose 70–90 mg/dL; HbA1c <5.4% Relevant only if pursued with a metabolic goal

Cadence: Reassess at end of course (~2–4 weeks), again at ~3 months, then every 6–12 months if maintenance continues

Qualitative Assessment

  • Perceived core strength and posture in daily activities
  • How clothing fits in the treated area
  • Frequency of urine leakage, for the pelvic-floor application
  • Confidence and satisfaction with the result
  • Whether functional strength in everyday tasks actually changes